NASDAQ: AEMD
Aethlon Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for AEMD

Based on 1 analyst offering 12 month price targets for Aethlon Medical Inc

Min Forecast
$7.00+1,690.28%
Avg Forecast
$7.00+1,690.28%
Max Forecast
$7.00+1,690.28%

Should I buy or sell AEMD stock?

Based on 1 analyst offering ratings for Aethlon Medical Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AEMD stock forecasts and price targets.

AEMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-15

1 of 1

Forecast return on equity

Is AEMD forecast to generate an efficient return?

Company
N/A
Industry
24.91%
Market
70.65%

Forecast return on assets

Is AEMD forecast to generate an efficient return on assets?

Company
N/A
Industry
12.79%

AEMD earnings per share forecast

What is AEMD's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.01
Avg 2 year Forecast
-$0.72

AEMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AEMD$0.39$7.00+1,690.28%Buy
NUWE$1.27$17.00+1,238.58%Strong Buy
SINT$3.73N/AN/A
AIMD$0.43N/AN/A
BMRA$0.29N/AN/A

Aethlon Medical Stock Forecast FAQ

Is Aethlon Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AEMD) stock is to Buy AEMD stock.

Out of 1 analyst, 0 (0%) are recommending AEMD as a Strong Buy, 1 (100%) are recommending AEMD as a Buy, 0 (0%) are recommending AEMD as a Hold, 0 (0%) are recommending AEMD as a Sell, and 0 (0%) are recommending AEMD as a Strong Sell.

If you're new to stock investing, here's how to buy Aethlon Medical stock.

What is AEMD's earnings growth forecast for 2025-2026?

(NASDAQ: AEMD) Aethlon Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.31%.

Aethlon Medical's earnings in 2024 is -$11,269,952.On average, 2 Wall Street analysts forecast AEMD's earnings for 2025 to be -$14,101,618, with the lowest AEMD earnings forecast at -$15,358,198, and the highest AEMD earnings forecast at -$12,845,038.

In 2026, AEMD is forecast to generate -$10,052,639 in earnings, with the lowest earnings forecast at -$10,052,639 and the highest earnings forecast at -$10,052,639.

What is AEMD's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: AEMD) forecast ROE is N/A, which is considered weak.

What is AEMD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AEMD price target, the average AEMD price target is $7.00, with the highest AEMD stock price forecast at $7.00 and the lowest AEMD stock price forecast at $7.00.

The Wall Street analyst predicted that Aethlon Medical's share price could reach $7.00 by Nov 15, 2025. The average Aethlon Medical stock price prediction forecasts a potential upside of 1,690.28% from the current AEMD share price of $0.39.

What is AEMD's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: AEMD) Aethlon Medical's current Earnings Per Share (EPS) is -$2.82. On average, analysts forecast that AEMD's EPS will be -$1.01 for 2025, with the lowest EPS forecast at -$1.10, and the highest EPS forecast at -$0.92. In 2026, AEMD's EPS is forecast to hit -$0.72 (min: -$0.72, max: -$0.72).

What is AEMD's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: AEMD) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.79%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.